These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12852400)

  • 21. Studies of central functional equivalence-I. Time-varying distribution of power in discrete frequency bands of the EEG as a function of drug exposure.
    Gehrmann JE; Killam KF
    Neuropharmacology; 1978 Sep; 17(9):747-59. PubMed ID: 99680
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaco-EEG profiles of typical and atypical antidepressants.
    Saletu B
    Adv Biochem Psychopharmacol; 1982; 32():257-68. PubMed ID: 7090895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings of the 12th International Symposium on Pharmaceutical and Biomedical Analysis. Monterey, California, USA. May 13-16, 2001.
    J Pharm Biomed Anal; 2002 Oct; 30(3):377-893. PubMed ID: 12701596
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypodermic cathode follower for drug administration and concurrent EEG recording.
    Runion HI; Riedesel CC
    J Pharm Sci; 1965 May; 54(5):781-2. PubMed ID: 5321125
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings of the 6th Annual Safety Pharmacology Society Meeting. San Diego, California, USA. September 26-28, 2006.
    J Pharmacol Toxicol Methods; 2007; 56(2):87-275. PubMed ID: 18309564
    [No Abstract]   [Full Text] [Related]  

  • 26. Some examples for the possibilities and limitations of pharmacoelectroencephalography as a method in clinical pharmacology.
    Herrmann WM
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():55S-76S. PubMed ID: 6119408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in drug responses.
    Franconi F; Brunelleschi S; Steardo L; Cuomo V
    Pharmacol Res; 2007 Feb; 55(2):81-95. PubMed ID: 17129734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Geriatric pharmacology].
    Petersen JK
    Tandlaegebladet; 1987 May; 91(8):382-5. PubMed ID: 3475806
    [No Abstract]   [Full Text] [Related]  

  • 29. Developmental pharmacology: past, present and future.
    Blumer JL
    Acta Paediatr Jpn; 1996 Dec; 38(6):555-61. PubMed ID: 9002286
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of tanakan on central nervous system function in patients with the residual manifestations of stroke].
    Kuznetsova SM; Glazovskaia II; Kuznetsov VV
    Lik Sprava; 1997; (6):132-4. PubMed ID: 9589957
    [No Abstract]   [Full Text] [Related]  

  • 31. Addressing Translational Research in Efficacy and Safety of New Medicines. Abstracts of the 2006 International Conference Frontiers of Pharmacology and Toxicology, August 28-31, 2006, Chicago, Illinois, USA.
    Chem Biol Interact; 2006 Jul; 161(3):177-226. PubMed ID: 16977696
    [No Abstract]   [Full Text] [Related]  

  • 32. Vigilance-controlled quantified EEG in safety pharmacology.
    Dürmüller N; Porsolt RD; Scherschlicht R
    Curr Protoc Pharmacol; 2001 May; Chapter 10():Unit 10.6. PubMed ID: 22293963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for human pharmacological functional magnetic resonance imaging (phMRI).
    Tracey I
    J Clin Pharmacol; 2001 Jul; 41(S7):21S-28S. PubMed ID: 11452725
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicology evaluation and single intravenous dose studies in human subjects.
    Colburn WA
    J Clin Pharmacol; 1997 Jan; 37(1):4-6. PubMed ID: 9048266
    [No Abstract]   [Full Text] [Related]  

  • 35. [1st meeting of the Society for Applied Pharmacological Sciences, Milan, 20 November 1965. Report of the Study Group for Screening Technics. General screening of activity and toxicity].
    Bonati F; Rosati G
    Boll Chim Farm; 1966 Aug; 105(8):575-83. PubMed ID: 6003363
    [No Abstract]   [Full Text] [Related]  

  • 36. Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging).
    Saletu B; Anderer P; Kinsperger K; Grünberger J
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):385-408. PubMed ID: 2888937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of drug interaction.
    Solomon HM; Barakat MJ; Ashley CJ
    JAMA; 1971 Jun; 216(12):1997-9. PubMed ID: 5108631
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-associated isoelectric EEGs. A hazard in brain-death certification.
    Powner DJ
    JAMA; 1976 Sep; 236(10):1123. PubMed ID: 988871
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacology of functional disorders of the urogenital system.
    Michel MC
    Br J Clin Pharmacol; 2011 Aug; 72(2):183-5. PubMed ID: 21564172
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.